The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
Recruiting · NCT07552285 · Observational (researchers observe without assigning treatment) · Lead sponsor: The First Affiliated Hospital of Soochow University
View the official record on ClinicalTrials.gov →Interventions studied
observational study
What this trial is about
The goal of this clinical trial aims to explore the diagnostic efficacy and grading of prostate cancer by a novel MRI sequences such as MAGiC，OGSE,CEST,IVIM,etc.The main question it aims to answer is: Can the novel non-contrast multiparametric MRI imaging improve the accuracy of diagnosis and grading of prostate cancer? For patients with clinical suspicion of prostate cancer, both conventional and new sequences magnetic resonance scans are conducted, with surgical or biopsy pathological results serving as the gold standard.
Who can take part
Age range
20 Years to 90 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patients with a high clinical suspicion of prostate cancer and elevated tPSA levels;
- Patients with no prior history of other tumors;
- Patients with no contraindications to MRI, including claustrophobia, presence of pacemakers, cardiac stents, or metal implants such as screws and plates.
Exclusion criteria
- The patient has a history of malignant tumors and has received corresponding treatment;
- Prior to the MRI examination, the patient has undergone treatment for prostate cancer, including endocrine therapy, radiotherapy, etc.;
- Patients who have previously undergone radical prostatectomy for prostate cancer.
Where it is running
1 location listed.
- The First Affiliated Hospital of Soochow University - Suzhou, Jiangsu, China